ZNF217 and ovarian carcinoma: Taken together, our data suggests that ZNF217 overexpression induces largescale gene expression changes in ovarian cancer cells, which increases their proliferation, suppresses apoptosis, promotes the acquisition of a more mesenchymal state, and induces extracellular matrix reorganization.